DEPOMED INC's ticker is and the CUSIP is 249908AA2. A total of 38 filers reported holding DEPOMED INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $3,713,000 | -16.0% | 5,000,000 | 0.0% | 0.03% | -12.1% |
| Q2 2017 | $4,419,000 | -47.7% | 5,000,000 | -44.4% | 0.03% | -50.7% |
| Q1 2017 | $8,457,000 | -17.5% | 9,000,000 | 0.0% | 0.07% | -18.3% |
| Q4 2016 | $10,257,000 | -18.0% | 9,000,000 | 0.0% | 0.08% | -7.9% |
| Q3 2016 | $12,510,000 | +15.4% | 9,000,000 | 0.0% | 0.09% | +17.1% |
| Q2 2016 | $10,838,000 | +28.9% | 9,000,000 | 0.0% | 0.08% | +35.7% |
| Q1 2016 | $8,408,000 | -18.6% | 9,000,000 | 0.0% | 0.06% | -15.2% |
| Q4 2015 | $10,327,000 | -67.3% | 9,000,000 | -65.8% | 0.07% | -69.7% |
| Q3 2015 | $31,575,000 | -25.7% | 26,329,000 | -20.4% | 0.22% | -16.8% |
| Q2 2015 | $42,480,000 | -4.2% | 33,071,000 | -1.1% | 0.26% | -5.8% |
| Q1 2015 | $44,320,000 | +109.2% | 33,423,000 | +71.4% | 0.28% | +98.6% |
| Q4 2014 | $21,186,000 | +2.4% | 19,500,000 | 0.0% | 0.14% | +1.4% |
| Q3 2014 | $20,693,000 | – | 19,500,000 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 8,078,000 | $5,958,000 | 3.38% |
| Shaolin Capital Management LLC | 10,167,000 | $7,584,000 | 1.17% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 10,635,000 | $7,844,000 | 1.14% |
| CSS LLC/IL | 3,917,000 | $2,921,000 | 0.19% |
| BlueCrest Capital Management Ltd | 3,000,000 | $2,234,000 | 0.15% |
| MOORE CAPITAL MANAGEMENT, LP | 4,000,000 | $2,980,000 | 0.12% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 2,100,000 | $1,564,000,000 | 0.04% |
| OAKTREE CAPITAL MANAGEMENT LP | 2,780,000 | $2,077,000 | 0.04% |
| Private Harbour Investment Management & Counsel, LLC | 25,000 | $18,000 | 0.02% |
| MACKAY SHIELDS LLC | 775,000 | $579,000 | 0.00% |